News
First Tysabri biosimilar cleared by FDA for MS
Sandoz and Polpharma Biologics have become the first companies to get FDA approval for a biosimilar of Biogen's blockbuster multiple sclerosis therapy Tysabri, after overc
Tuesday 1 April 2025
